Table of Contents
What changed
Property revenue rose 7.4% to $126.4m and operating profit climbed 12.2% to $84.6m. The headline, however, is the accounting swing below the line: PBT moved from a $24.9m loss to a $54.7m profit (+$79.7m), with NPAT swinging from –$36.5m to $43.2m. Against only $8.7m of incremental revenue, the scale of that swing points to non-cash items (most plausibly investment property fair-value movements) rather than underlying operating step-up.
Cash told a different story. Operating cash flow fell 22.6% to $37.0m despite higher reported earnings. Capex eased to $64.3m (from $87.8m), but pre-lease free cash flow remained negative at –$27.3m. Gross borrowings rose 13.6% to $1,255.6m and cash fell to $13.8m, lifting net debt to roughly $1.24b from $1.09b. The interim dividend was cut 5.3% to 1.35 cps. Mixed-use continues to dominate mix at 63.5% of segment revenue (+2.7pp), with Office and Retail broadly stable in absolute terms.
What matters
- PBT/NPAT reversal is accounting-heavy. Operating profit rose a more modest 12.2%, and the $79.7m PBT swing on $8.7m of revenue growth is disproportionate to any operating improvement. Readers should treat the reported NPAT recovery as flattered by revaluation mechanics rather than a clean earnings step-up. PBT growth of 319% is the cleaner read only in a directional sense; on an operating basis, the 12.2% lift in operating profit is the more defensible indicator.
- Leverage direction is unambiguously weakening. Gross borrowings up $150.2m, cash down, equity essentially flat at $1,870.4m. Total liabilities grew 12.2% against 5.0% asset growth. The balance sheet is absorbing capex and distributions while the development pipeline continues.
- Distribution policy has tightened. The 5.3% DPS cut alongside a pre-lease FCF deficit is consistent with management rebalancing payout to cash reality. Interim payout is 49.6% of NPAT but not covered by pre-lease free cash flow.
Expectations
No forward work metric, NTA disclosure, or formal guidance was present in the supplied materials, so a direct run-rate versus target check is not possible. On seasonality, HY24 was 48.1% of FY24 revenue, suggesting a mildly second-half weighted shape; annualising HY25 at $256.7m implies roughly 4.9% above FY24 revenue of $244.7m if that pattern holds. The HY24 NPAT base was loss-making, so the implied H2 FY24 NPAT of $34.4m is not a useful comparator for HY25 earnings trajectory – it reflects a revaluation reversal pattern rather than operating seasonality.
Quality of result
The durable portion of the result is the operating line: revenue +7.4%, operating profit +12.2%, and segment-level margins holding in the mid-70s for Mixed-use, Office and Retail. That is a credible leasing-led story.
The rest is harder to underwrite. The NPAT swing of $79.8m materially outpaces operating profit growth of $9.2m, strongly implying fair-value and/or financing-line movements that are not repeatable. Operating cash fell 22.6% despite the stronger P&L – a direct cash-conversion deterioration that the release does not reconcile. Operating working capital rose $8.9m to $90.2m, inventories stood at $80.9m, and receivable days extended modestly (13.2 vs 12.1). The combination of accounting profit up, cash down and debt up is a classic signal that earnings quality lags the headline.
Unresolved
- What portion of the PBT swing is investment property fair-value gains versus operating improvement? The materials do not separate this.
- Why did operating cash fall 22.6% when operating profit rose 12.2%? The 22.6% drop is not reconciled against the $8.9m working-capital build alone.
- What is NTA per share post-result, and how has the valuation change flowed through portfolio cap rates?
- Is the 1.35 cps interim a step toward a lower sustainable payout, or a one-period adjustment? No full-year DPS guidance is provided.
- With gearing rising and development capex continuing, what is the funding path – further debt, asset sales, or equity?
This briefing cannot assess portfolio valuation mechanics, tenant concentration, or specific development pipeline economics, because none of those disclosures were present in the supplied materials.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $126.4m | $117.7m | +7.4% ↑ |
| Net profit after tax | $43.2m | −$36.5m | +218.3% ↑ |
| Net cash inflow from operating activities | $37.0m | $47.8m | -22.6% ↓ |
| Interim dividend per share | 1.4c | 1.4c | -5.3% ↓ |
| Operating profit | $84.6m | $75.4m | +12.2% ↑ |
| Profit before tax | $54.7m | −$24.9m | +319.4% ↑ |
| Cash and cash equivalents | $13.8m | $15.9m | -13.4% ↓ |
| Total assets | $3300.0m | $3143.6m | +5.0% ↑ |
Reference: annolyse.ai/briefings/kpg-hy25
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Mixed-use | $80.2m | $70.3m | $60.5m | +2.7pp |
| Office | $32.4m | $31.5m | $23.4m | -1.7pp |
| Retail | $13.6m | $13.3m | $10.7m | -0.7pp |
| Other | $0.2m | $0.5m | −$0.0m | -0.3pp |
Reference: annolyse.ai/briefings/kpg-hy25
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| Effective tax rate | 21.0% | n/m (loss period) | prior loss period |
| FCF pre-lease | −$27.3m | −$40.0m | +$12.7m |
| FCF / NPAT | -63.2% | 109.3% | complementary conversion metric |
| Capex % revenue | 50.1% | 74.6% | — |
| Capex | −$64.3m | $87.8m | −$152.1m |
| Debtor days | 13.2 | 12.1 | +1.1 days |
| Inventory days | 114.8 | 113.7 | +1.1 days |
| Operating working capital | $90.2m | $81.3m | +$8.9m absorbed |
| Trade debtors | $9.3m | $7.8m | +$1.5m |
| Net debt | $1241.8m | $1089.5m | +$152.3m |
| Gross borrowings | $1255.6m | $1105.4m | +$150.2m |
| Payout ratio vs NPAT | 49.6% | — | — |
| ROE (annualised) | 2.3% | -2.0% | Strengthening |
| HY24 share of FY24 revenue | 48.1% | — | Other half was 51.9% |
| HY24 share of FY24 NPAT | n/m | — | Other half was n/m |
| Profit from continuing operations | $43.2m | −$36.5m | +$79.8m |
Reference: annolyse.ai/briefings/kpg-hy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.